etilefrine has been researched along with Obesity in 1 studies
Etilefrine: A phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pasquali, R | 1 |
| Cesari, MP | 1 |
| Besteghi, L | 1 |
| Melchionda, N | 1 |
| Balestra, V | 1 |
1 other study available for etilefrine and Obesity
| Article | Year |
|---|---|
Thermogenic agents in the treatment of human obesity: preliminary results.
Topics: Adult; Ephedrine; Etilefrine; Female; Humans; Obesity; Phenylephrine | 1987 |